HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the
latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored:
- New Treatments Targeting Hepatitis B Start Clinical Trials Soon
- Experts Urge Doctors to Screen Pregnant Women for Both Hepatitis B and High Viral Loads
- Using Antivirals Early in a Pregnancy Reduces Infection of Newborns
- Some Pregnant Women in U.S. Still Not Getting Screened for HBV and STIs
- High Viral Loads in Men Increase the Amount of HBV DNA in Their Sperm
- Despite Vaccine, Rural States See Rise in Hepatitis B Due to Heroin Use
- More Than Half of Young Drug Users Are Not Vaccinated Against Hepatitis A and B
- Shorter Vaccination Schedule Works to Prevent Infection Among Drug Users
- Generic Entecavir Could Treat All Patients Worldwide for $36 a Year
- Reformulated Tenofovir Appears Better at Fighting Infection in Liver Cells
- Another Report Calls for Doctors to Screen All Patients for HBV Before Starting Chemotherapy
- Study Confirms Aflatoxins Increase Liver Cancer in Hepatitis B Patients
Continue reading "HBV Journal Review – May 2015"
